More than 250 million chronic patients with Hepatitis B are not in the shadow of COVID-19
VBIV

VBI Vaccines (CTO: VBIV) is a biopharmaceutical company that is starting to make a name for itself by developing a new generation of vaccines in the commercial phase of the process. These include infectious diseases and immuno-oncology. Although the company is researching a pan-coronavirus vaccine for COVID-19 in collaboration with the National Research Council of…

CytoDyn Executes Exclusive Agreement with American Regent: Stock Turns Volatile
CYDY

CytoDyn Executes Exclusive Agreement with American Regent: Stock Turns Volatile The coronavirus pandemic has been nothing short of a disaster for business across a wide range of sectors. However, there is a small collection of companies that have actually performed well in the stock markets due to their work regarding tackling the pandemic. One such company…